400 related articles for article (PubMed ID: 25875862)
1. Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis.
González-Ortega I; Alberich S; Echeburúa E; Aizpuru F; Millán E; Vieta E; Matute C; González-Pinto A
PLoS One; 2015; 10(4):e0123707. PubMed ID: 25875862
[TBL] [Abstract][Full Text] [Related]
2. Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.
van der Meer FJ; Velthorst E;
Psychol Med; 2015 Jul; 45(9):1977-88. PubMed ID: 25654244
[TBL] [Abstract][Full Text] [Related]
3. Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study).
Baeza I; Graell M; Moreno D; Castro-Fornieles J; Parellada M; González-Pinto A; Payá B; Soutullo C; de la Serna E; Arango C
Schizophr Res; 2009 Sep; 113(2-3):129-37. PubMed ID: 19427172
[TBL] [Abstract][Full Text] [Related]
4. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).
Tosato S; Lasalvia A; Bonetto C; Mazzoncini R; Cristofalo D; De Santi K; Bertani M; Bissoli S; Lazzarotto L; Marrella G; Lamonaca D; Riolo R; Gardellin F; Urbani A; Tansella M; Ruggeri M;
J Psychiatr Res; 2013 Apr; 47(4):438-44. PubMed ID: 23290558
[TBL] [Abstract][Full Text] [Related]
5. [Search association between cannabis abuse and bipolar disorder: A study on a sample of patients hospitalized for bipolar disorder].
Kazour F; Awaida C; Souaiby L; Richa S
Encephale; 2018 Feb; 44(1):14-21. PubMed ID: 27745717
[TBL] [Abstract][Full Text] [Related]
6. Depressive symptoms in first-episode psychosis: a 10-year follow-up study.
Sönmez N; Røssberg JI; Evensen J; Barder HE; Haahr U; Ten Velden Hegelstad W; Joa I; Johannessen JO; Langeveld H; Larsen TK; Melle I; Opjordsmoen S; Rund BR; Simonsen E; Vaglum P; McGlashan T; Friis S
Early Interv Psychiatry; 2016 Jun; 10(3):227-33. PubMed ID: 24956976
[TBL] [Abstract][Full Text] [Related]
7. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study.
Degenhardt L; Tennant C; Gilmour S; Schofield D; Nash L; Hall W; McKay D
Psychol Med; 2007 Jul; 37(7):927-34. PubMed ID: 17288638
[TBL] [Abstract][Full Text] [Related]
8. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
[TBL] [Abstract][Full Text] [Related]
9. Cannabis abuse as a risk factor for depressive symptoms.
Bovasso GB
Am J Psychiatry; 2001 Dec; 158(12):2033-7. PubMed ID: 11729021
[TBL] [Abstract][Full Text] [Related]
10. Cannabis use predicts shorter duration of untreated psychosis and lower levels of negative symptoms in first-episode psychosis: a South African study.
Burns JK; Jhazbhay K; Emsley R
Afr J Psychiatry (Johannesbg); 2010 Nov; 13(5):395-9. PubMed ID: 21390411
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive and social cognitive predictors of cannabis use in first-episode psychosis.
Arnold C; Allott K; Farhall J; Killackey E; Cotton S
Schizophr Res; 2015 Oct; 168(1-2):231-7. PubMed ID: 26260081
[TBL] [Abstract][Full Text] [Related]
12. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation.
Stone JM; Fisher HL; Major B; Chisholm B; Woolley J; Lawrence J; Rahaman N; Joyce J; Hinton M; Johnson S; Young AH;
Psychol Med; 2014 Feb; 44(3):499-506. PubMed ID: 23701858
[TBL] [Abstract][Full Text] [Related]
13. Cannabis abuse and severity of psychotic and affective disorders in Israeli psychiatric inpatients.
Katz G; Durst R; Shufman E; Bar-Hamburger R; Grunhaus L
Compr Psychiatry; 2010; 51(1):37-41. PubMed ID: 19932824
[TBL] [Abstract][Full Text] [Related]
14. Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial.
Clausen L; Hjorthøj CR; Thorup A; Jeppesen P; Petersen L; Bertelsen M; Nordentoft M
Psychol Med; 2014 Jan; 44(1):117-26. PubMed ID: 23590927
[TBL] [Abstract][Full Text] [Related]
15. Working memory as a predictor of negative symptoms and functional outcome in first episode psychosis.
González-Ortega I; de Los Mozos V; Echeburúa E; Mezo M; Besga A; Ruiz de Azúa S; González-Pinto A; Gutierrez M; Zorrilla I; González-Pinto A
Psychiatry Res; 2013 Mar; 206(1):8-16. PubMed ID: 22985548
[TBL] [Abstract][Full Text] [Related]
16. The association between cognitive deficits and depressive symptoms in at-risk mental state: a comparison with first-episode psychosis.
Ohmuro N; Matsumoto K; Katsura M; Obara C; Kikuchi T; Hamaie Y; Sakuma A; Iizuka K; Ito F; Matsuoka H
Schizophr Res; 2015 Mar; 162(1-3):67-73. PubMed ID: 25618299
[TBL] [Abstract][Full Text] [Related]
17. Apathy in first episode psychosis patients: one year follow up.
Faerden A; Finset A; Friis S; Agartz I; Barrett EA; Nesvåg R; Andreassen OA; Marder SR; Melle I
Schizophr Res; 2010 Jan; 116(1):20-6. PubMed ID: 19948392
[TBL] [Abstract][Full Text] [Related]
18. Pre-morbid Conduct Disorder symptoms are associated with cannabis use among individuals with a first episode of psychosis.
Malcolm CP; Picchioni MM; DiForti M; Sugranyes G; Cooke E; Joseph C; McQueen G; Paparelli A; Stilo S; O'Connor J; Morgan C; Murray RM; Hodgins S
Schizophr Res; 2011 Mar; 126(1-3):81-6. PubMed ID: 21186097
[TBL] [Abstract][Full Text] [Related]
19. Medication adherence mediates the impact of sustained cannabis use on symptom levels in first-episode psychosis.
Faridi K; Joober R; Malla A
Schizophr Res; 2012 Oct; 141(1):78-82. PubMed ID: 22910403
[TBL] [Abstract][Full Text] [Related]
20. Social functioning trajectories of young first-episode psychosis patients with and without cannabis misuse: a 30-month follow-up study.
González-Blanch C; Gleeson JF; Koval P; Cotton SM; McGorry PD; Alvarez-Jimenez M
PLoS One; 2015; 10(4):e0122404. PubMed ID: 25849623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
